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Elucidation of the Signaling Pathway of MERTK 
 
Background 
Mer Tyrosine Kinase (MERTK) is a receptor which mediates efferocytosis – removal of 
apoptotic cells by phagocytes such as macrophages. MERTK plays a critical role in homeostasis, 
with mutations in MERTK associated with the development and progression of atherosclerosis, 
the buildup of cholesterol-laden plaque in the sub-arterial space. Indeed, one MERTK allele is 
associated with 66% (heterozygous) to 75% (homozygous) protection from atherosclerosis, 
while other alleles and SNP’s pre-dispose to atherosclerosis and autoimmunity. Complications 
resulting from atherosclerosis, including heart attack and stroke, are currently the second leading 
cause of mortality in Canada. Despite the importance of MERTK in atherosclerosis and other 
clinical conditions, little is known of its signaling or regulation. My project is focused on 
identifying the downstream signaling pathway triggered by MERTK activation and determining 
how atherosclerosis alters signaling through this pathway. 
Methods 
MERTK will be activated in human macrophages under homeostatic conditions and associated 
downstream signaling molecules identified. These signaling molecules will then be prioritized 
based on their known function, and their roles elucidated through efferocytosis assays using cells 
treated with inhibitors against the proteins of interest. Finally, the activity and expression of key 
signaling molecules will be assessed in a model of atherosclerosis.  
Expected Results 
My project will potentially reveal the signaling pathway utilized by MERTK for efferocytosis 
and clarify MERTK’s role in atherosclerosis development and progression. 
Discussion/Conclusion and Interdisciplinary Reflection 
The findings generated by this project may lead to the development of putative therapies aimed 
at treating cases of advanced atherosclerosis and its associated complications. 
 
